(-)-Epigallocatechin-3-gallate inhibits Met signaling, proliferation, and invasiveness in human colon cancer cells.
about
Epigenetics Offer New Horizons for Colorectal Cancer PreventionLifestyle Modifications and Colorectal CancerNutraceutical use in late-stage cancer.Plants vs. cancer: a review on natural phytochemicals in preventing and treating cancers and their druggabilityMatrix metalloproteinases and gastrointestinal cancers: Impacts of dietary antioxidants.Identifying molecular targets of lifestyle modifications in colon cancer prevention.Comparison of anti-inflammatory mechanisms of mango (Mangifera Indica L.) and pomegranate (Punica Granatum L.) in a preclinical model of colitisTea catechins as inhibitors of receptor tyrosine kinases: mechanistic insights and human relevance.Endothelins and their receptors in cancer: identification of therapeutic targets.Cancer chemoprevention with green tea catechins by targeting receptor tyrosine kinases.Flavonoids, a ubiquitous dietary phenolic subclass, exert extensive in vitro anti-invasive and in vivo anti-metastatic activities.Dietary phytochemicals in cancer prevention and therapy: a complementary approach with promising perspectives.Multifaceted ability of naturally occurring polyphenols against metastatic cancer.Absorption, metabolism, anti-cancer effect and molecular targets of epigallocatechin gallate (EGCG): An updated review.Epigallocatechin-3-gallate induces growth inhibition and apoptosis of human anaplastic thyroid carcinoma cells through suppression of EGFR/ERK pathway and cyclin B1/CDK1 complex.Chromatin accessibility underlies synthetic lethality of SWI/SNF subunits in ARID1A-mutant cancers.Biological and Mechanistic Characterization of Novel Prodrugs of Green Tea Polyphenol Epigallocatechin Gallate Analogs in Human Leiomyoma Cell Lines.Phytochemicals for the treatment of inflammatory bowel diseases
P2860
Q22252606-AB29909A-3500-4B9C-856A-9D58E5C6E1CCQ26865414-194506DD-2F61-47F4-9DD9-7A2A368CB9D7Q27693359-3A02004A-19FD-4EB7-A035-28D257E063A1Q28385642-86CDEDB6-0343-49CF-830B-DE513400CD8DQ34161592-91691ACE-FE17-4C57-97B1-4549B29784FFQ34651881-08CE7AF8-EFBC-425F-A75B-37A9D68932E6Q37262589-19681249-069A-413F-82FA-061578D567EEQ37778421-C1E2A06E-0488-40C4-85C1-11FEBB9BA331Q37830914-89D8D31B-3CA6-40EB-A9CD-788006BA726CQ37871559-5D4E9581-A97D-45E4-927E-D2711EC9F465Q37982235-B9033B79-1DFA-4E2E-9672-8FDE063FF3ADQ38137099-6663A476-4F9B-4616-8406-E7286EDE28AAQ38698686-03A62990-8FD7-4402-A1B5-078347C50640Q38958946-63908660-7F5A-46F3-A386-D6B5034ADBD8Q39513352-2072C223-179A-4CB1-8325-3A3D9B65708DQ42378723-F68DA601-F231-4D88-AD2D-B31176E43136Q46840249-945C7F67-379F-4A2A-801E-6D90015D56DAQ58595158-70D1741F-B151-4E94-87E5-2F4687EA6FB0
P2860
(-)-Epigallocatechin-3-gallate inhibits Met signaling, proliferation, and invasiveness in human colon cancer cells.
description
2010 nî lūn-bûn
@nan
2010 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մարտին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
(-)-Epigallocatechin-3-gallate ...... s in human colon cancer cells.
@ast
(-)-Epigallocatechin-3-gallate ...... s in human colon cancer cells.
@en
(-)-Epigallocatechin-3-gallate ...... s in human colon cancer cells.
@nl
type
label
(-)-Epigallocatechin-3-gallate ...... s in human colon cancer cells.
@ast
(-)-Epigallocatechin-3-gallate ...... s in human colon cancer cells.
@en
(-)-Epigallocatechin-3-gallate ...... s in human colon cancer cells.
@nl
prefLabel
(-)-Epigallocatechin-3-gallate ...... s in human colon cancer cells.
@ast
(-)-Epigallocatechin-3-gallate ...... s in human colon cancer cells.
@en
(-)-Epigallocatechin-3-gallate ...... s in human colon cancer cells.
@nl
P2860
P1476
(-)-Epigallocatechin-3-gallate ...... s in human colon cancer cells.
@en
P2093
Christine A Larsen
Roderick H Dashwood
P2860
P356
10.1016/J.ABB.2010.03.017
P407
P577
2010-03-31T00:00:00Z